Hemangiopericytoma Overview
Learn About Hemangiopericytoma
View Main Condition: Brain Tumor
- Hemangiopericytoma
Aligned Orthopedic Partners
Board Certified in Orthopaedic Surgery and also in Hand Surgery, Dr. Bieber is interested in all areas of orthopedics, with a special interest in reconstruction, trauma, arthroscopy, and sports medicine of the upper extremity, including the hand, wrist, elbow, and shoulder. He has expertise in arthroscopic surgery of the shoulder and shoulder replacement surgery. A graduate of Yale University and Georgetown Medical School, his orthopedic training was at Johns Hopkins University with a fellowship in hand and upper extremity at the Mayo Clinic. He is a consultant for hand and upper extremity surgery at the National Institutes of Health. Dr. Bieber has served as Chairman of the Department of Surgery and Chairman of the Medical Staff at Suburban Hospital and as President of the Washington Orthopaedic Society.SpecialtiesUpper Extremity (hand, wrist, elbow, shoulder)PrivilegesDr. Bieber performs surgery at Surgical Specialty Center of Mid-Atlantic, Suburban Hospital, Sibley Memorial Hospital, Bethesda Chevy Chase Surgery Center, Surgical Specialty Center of Mid-Atlantic, and Advanced Surgery Center of Bethesda. Dr. Bieber is rated as an Advanced provider by MediFind in the treatment of Hemangiopericytoma. His top areas of expertise are Synovitis, Tendinitis, Tenosynovitis, and Trigger Thumb.
Angela Sardaro practices in Lecce, Italy. Ms. Sardaro is rated as an Elite expert by MediFind in the treatment of Hemangiopericytoma. Her top areas of expertise are Hemangiopericytoma, Hemangioendothelioma, Prostate Cancer, Hemosiderosis, and Prostatectomy.
Caroline Apra practices in Creteil, France. Ms. Apra is rated as an Elite expert by MediFind in the treatment of Hemangiopericytoma. Her top areas of expertise are Hemangiopericytoma, Solitary Fibrous Tumor, Meningioma, Brain Tumor, and Microvascular Decompression.
Summary: Every new classification depends on its prognostic power and on the type of treatment given. With the rapid evolution of diagnostic methods and the advance in new treatments, there is much less reliable information available on how patients with newly defined brain tumour entities should be treated and what to expect from the current treatments. The goal is to determine whether the new 2021 WHO cl...
Summary: The first proton therapy treatments in the Netherlands have taken place in 2018. Due to the physical properties of protons, proton therapy has tremendous potential to reduce the radiation dose to the healthy, tumour-surrounding tissues. In turn, this leads to less radiation-induced complications, and a decrease in the formation of secondary tumours. The Netherlands has spearheaded the development ...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
